Navigation Links
UCI Liver Program jinxed with 4 more lawsuits

University of California was slapped with four additional law suits, after the Liver Transplant Program of the UCI Medical center had failed miserably. //

Orange county Superior court has been a witness to three claims filed by the families of patients who died just waiting for the transplants; the fourth, a patient who never received a liver.

The liver transplant program transparent to gross mismanagement has to also battle the 50 plus lawsuits that have been filed.

UCI was prompted to close the program in November soon after The Times reported that 32 patients died while waiting for transplants. At this time the UCI had also refused many livers that were worthy of transplant, because of paucity of surgeons to perform the transplant operation.


'"/>




Page: 1

Related medicine news :

1. Blood Cells Capable of Regenerating Liver
2. Liver donors can thrive after transplant
3. Heavy Drinking Raises Risk of Liver Cancer
4. Arthritis Drug May Cause Liver Damage
5. Liver transplant oversight urged
6. Liver key to extending life
7. Liver cancers which spread are linked to a particular gene
8. Liver diseases: The enemy with an accomplice
9. Troubled Childhood found to affect your Liver
10. New Liver Tumor Treatment
11. Transplants Help Liver Cancer Patients
Post Your Comments:
(Date:11/21/2008)...-FirstCall/ -- Alseres,Pharmaceuticals, Inc. (Nas... into,a securities purchase agreement with Robert...es of common stock of the Company, together with w...common stock at an exercise price of,$1.84 per sh.... The financing,resulted in total gross proceeds...
(Date:11/21/2008)...rneys representing consumers and,third-party paye...n settlement,with healthcare services giant McKes...any fraudulently inflated the price of more than 4...g benchmarks. , (Logo: http://www.newscom....e lawsuit, filed under the Racketeer Influenced an...
(Date:11/21/2008)...Call/ -- Escalon Medical Corp. (Nasdaq: ESMC ) t...eted a $1,100,000 private placement of common stoc... and institutional investors. The Company sold 1,... The investors also received warrants to purchase...n exercise price of $1.21 per share. The warrants...
(Date:11/21/2008)...ire-FirstCall/ -- DATATRAK,International, Inc. (N... focused,on global eClinical solutions for the cl...lliance partner in Japan, NTT DATA Corporation, ha...e DATATRAK eClinical platform into production,for...t of this first,independently designed clinical t...
Breaking Medicine News(10 mins):Health News:Alseres Pharmaceuticals, Inc. Announces $1 Million Financing 2Health News:Alseres Pharmaceuticals, Inc. Announces $1 Million Financing 3Health News:Hagens Berman Sobol Shapiro: McKesson Settles RICO Lawsuit for $350 Million 2Health News:Hagens Berman Sobol Shapiro: McKesson Settles RICO Lawsuit for $350 Million 3Health News:Escalon(R) Medical Corp. Completes $1.1 Million Private Equity Financing 2Health News:Escalon(R) Medical Corp. Completes $1.1 Million Private Equity Financing 3Health News:NTT DATA Launches First Self-Designed DATATRAK eClinical(TM) Project Into Production in Japan 2Health News:NTT DATA Launches First Self-Designed DATATRAK eClinical(TM) Project Into Production in Japan 3
... Spanish fashion show, the Pasarela Cibeles, has r...too thin//,the show's nutritionist said. "Some of...ss index of 16 - the equivalent of being 1.80 mete...0 kg," said Susana Monereo, who sets the standards...
... women may be genetically predisposed to giving bi...hington University//. The research is an importa... delivering babies too early and eventually could ...s at the university examined 711,015 records of bi...
...sian health officials have doomsday predictions fo...sures are taken// to curb HIV/AIDS infection. Ac...try of Malaysia, the country will have a head coun...son by 2015. Of a population of 30 million, 73 th...
...tani authorities on Thursday expressed confidence ...tbreaks of the deadly// H5N1 strain of bird flu, a...e north. "The season is yet not over [for bird f... and surveillance arrangements in place to check a...
Other Medicine News:Health News:Genes May Trigger Repeated Premature Birth In Blacks 2Health News:Pakistan: Authorities Plays Down Bird Flu Risk 2
(Date:11/20/2008)...ROMSO, Norway, November 20 The Sca...opharma has announced results of studies on its,l...ICAAC in Washington, DC,the studies showed that ...,bacteriocidal effect, significantly better toward... pyogenes than marketed gold standard drugs. In,a...
(Date:11/19/2008)...AND OAKS, Calif., Nov. 19 /PRNewswire-FirstCall/ -...eda Oncology Company, a subsidiary of,Takeda Phar...unced that,enrollment in the Phase 3 MONET1 trial...th paclitaxel and carboplatin for the first-line t...NSCLC) has been temporarily suspended,following a...
(Date:11/19/2008)...ude scientists report basic findings on critical e...ow to better treat an array of disorders , , ...-- Scientists at St. Jude Children,s Research Hos...one of the body,s enzyme workhorses called calpain...rs, calpains function in many cellular processes, ...
(Date:11/19/2008)...K, Del., Nov. 19 Isogen, a contrac...sterile filling, today announced the first,phase ...n was founded to,specifically address the process...ted with the $2 billion highly-niched, low-volume ...ng market segment. , Companies can invest o...
Breaking Medicine Technology:Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3Isogen Launches Major New Facility to Address Global Biopharma Demand 2Health Secretary Urges Pennsylvanians to Get a Flu Shot 2527 1Health Secretary Urges Pennsylvanians to Get a Flu Shot 2527 2Prestigious Bioethics Award for Scholar from Mexico 963 1Prestigious Bioethics Award for Scholar from Mexico 963 2Stop eating for two 3A obese moms to be should gain less weight than currently recommended 2520 1Stop eating for two 3A obese moms to be should gain less weight than currently recommended 2520 2PDL BioPharma to Actively Seek Sale of Entire Company or Its Key Assets 2515 1PDL BioPharma to Actively Seek Sale of Entire Company or Its Key Assets 2515 2PDL BioPharma to Actively Seek Sale of Entire Company or Its Key Assets 2515 3
...sults from a Children,s Oncology Group (COG) Study...y Annual Meeting -, CHICAGO, June 04, 2007 /PRNews...aceutical company focused on developing monoclonal...ases, today,announced that treatment with epratuzu...l tolerated in children with,B-precursor acute lym...
...l pre-specified subset analyses of progression-fre... demonstrate a reduction in,relative risk of disea... These analyses included prior Taxotere use,geogr...HICAGO, June 04, 2007 /PRNewswire-FirstCall/ -- Ph...ced the presentation of,additional data from the d...
Other Medicine Technology:Promising Results with Epratuzumab and Chemotherapy in Children,with Acute Lymphoblastic Leukemia 2Promising Results with Epratuzumab and Chemotherapy in Children,with Acute Lymphoblastic Leukemia 3Promising Results with Epratuzumab and Chemotherapy in Children,with Acute Lymphoblastic Leukemia 4Promising Results with Epratuzumab and Chemotherapy in Children,with Acute Lymphoblastic Leukemia 5Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 2Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 3Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 4Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 5Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 6Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 7
..., in shorter exam lanes, where images from a stand... individual charts are available. Charts are contr... CV-3000 Vision Testing System, using the CV Keypa...ingle letter, horizontal line or vertical line. Th...
If youre looking to expand your projection capabilities, without a major capital investment, consider Topcons CP-5D Chart Projector.
This isnt just another new stand weve come up with, this is absolutely revolutionary!
Topcon offers an all-metal Trial Frame that is durably constructed, yet lightweight. It features a practical screw-thread design that extends the life of the trial frame by allowing for easy replacem
Medicine Products: